Madrigal Pharmaceuticals (MDGL) Q3 2026 Earnings

11AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-5.08
-3.69
-2.29
-0.9

Details

Expected EPS
-2.752628
Actual EPS
N/A
Surprise EPS
2.75
Surprise Percent
+100%

Description

Madrigal Pharmaceuticals (MDGL) will report earnings of for Q3 2026 on August 11, 2026.

0 Comments

Share your thoughts